Abstract
The article by Tandon et al.1 in this issue of the Journal highlights one of the most important areas of research in clinical oncology today — the search for better means of predicting the risk of a recurrence in women after local and regional treatment of breast cancer that appears to be localized. The population of women to whom such information is directly applicable is large; an estimated 150,000 women will be given a diagnosis of breast cancer in 1990 (Silverberg E: personal communication), and about half will have disease that is apparently confined to the breast, with no axillary-lymph-node …
| Original language | English (US) |
|---|---|
| Pages (from-to) | 329-331 |
| Number of pages | 3 |
| Journal | New England Journal of Medicine |
| Volume | 322 |
| Issue number | 5 |
| DOIs | |
| State | Published - Feb 1 1990 |
ASJC Scopus subject areas
- Medicine(all)